Literature DB >> 16702976

Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood.

C Glorioso1, M Sabatini, T Unger, T Hashimoto, L M Monteggia, D A Lewis, K Mirnics.   

Abstract

Brain-derived neurotrophic factor (BDNF) has been reported to be critical for the development of cortical inhibitory neurons. However, the effect of BDNF on the expression of transcripts whose protein products are involved in gamma amino butric acid (GABA) neurotransmission has not been assessed. In this study, gene expression profiling using oligonucleotide microarrays was performed in prefrontal cortical tissue from mice with inducible deletions of BDNF. Both embryonic and adulthood ablation of BDNF gave rise to many shared transcriptome changes. BDNF appeared to be required to maintain gene expression in the SST-NPY-TAC1 subclass of GABA neurons, although the absence of BDNF did not alter their general phenotype as inhibitory neurons. Furthermore, we observed expression alterations in genes encoding early-immediate genes (ARC, EGR1, EGR2, FOS, DUSP1, DUSP6) and critical cellular signaling systems (CDKN1c, CCND2, CAMK1g, RGS4). These BDNF-dependent gene expression changes may illuminate the biological basis for transcriptome changes observed in certain human brain disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702976     DOI: 10.1038/sj.mp.4001835

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  53 in total

Review 1.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Fine-tuning MAPK signaling in the brain: The role of MKP-1.

Authors:  Freddy Jeanneteau; Katrin Deinhardt
Journal:  Commun Integr Biol       Date:  2011-05

Review 3.  Sharing and reusing gene expression profiling data in neuroscience.

Authors:  Xiang Wan; Paul Pavlidis
Journal:  Neuroinformatics       Date:  2007

4.  Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

Authors:  Gianluigi Guidotti; Francesca Calabrese; Francesca Auletta; Jocelien Olivier; Giorgio Racagni; Judith Homberg; Marco A Riva
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

5.  GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.

Authors:  Etienne Sibille; Harvey M Morris; Rama S Kota; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2011-07       Impact factor: 5.176

6.  Inhibition of the Epigenetic Regulator REST Ameliorates Ischemic Brain Injury.

Authors:  Kahlilia C Morris-Blanco; TaeHee Kim; Mario J Bertogliat; Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Mol Neurobiol       Date:  2018-07-23       Impact factor: 5.590

7.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

8.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

9.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Meta-coexpression conservation analysis of microarray data: a "subset" approach provides insight into brain-derived neurotrophic factor regulation.

Authors:  Tamara Aid-Pavlidis; Pavlos Pavlidis; Tõnis Timmusk
Journal:  BMC Genomics       Date:  2009-09-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.